Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + methylprednisolone
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Topical, Intralesional, Intraarticular, Intramuscular
01
Overview
This entry appears to describe a **multi-ingredient topical or locally administered combination** containing povidone-iodine, lidocaine hydrochloride, isopropyl alcohol, and methylprednisolone. Pharmacologically, povidone-iodine acts as a broad-spectrum antiseptic by releasing free iodine that oxidizes and iodinate microbial proteins and nucleotides; isopropyl alcohol serves as a rapid skin disinfectant through protein denaturation and membrane disruption; lidocaine hydrochloride is a local anesthetic that blocks voltage-gated sodium channels to reduce nerve conduction and pain; and methylprednisolone is a glucocorticoid receptor agonist that suppresses inflammatory gene transcription. However, the supplied supporting text actually pertains to **methylprednisolone acetate injectable suspension alone**, not to this exact four-ingredient combination, and no specific branded or development-stage drug corresponding to the exact combination was established from the provided context. As such, this should be treated as an unverified combination-drug name rather than a clearly identified marketed or clinical asset.
- Other names
- povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + methylprednisolone
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + methylprednisolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + isopropyl alcohol + methylprednisolone.